logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11214540 B1

PDFFull Text
Date of Patent:
Jan. 04, 2022

Filed:

May. 15, 2018

Compositions for treating neurodegenerative diseases

Applicant:

Cognition Therapeutics, Inc., Pittsburgh, PA (US);

Inventors:

Gilbert M. Rishton, Los Angeles, CA (US);

Gary C. Look, Santa Clara, CA (US);

Susan M. Catalano, Pittsburgh, PA (US);

Assignee:

Cognition Therapeutics, Inc., Pittsburgh, PA (US);

Attorney:

Troutman Pepper Hamilton Sanders LLP

Primary Examiner:

Jeffrey H Murray

Int. Cl.
CPC ...
C07D 491/107 (2006.01); C07D 205/04 (2006.01); C07D 207/08 (2006.01); C07D 207/16 (2006.01); C07D 211/22 (2006.01); C07D 211/46 (2006.01); C07D 211/48 (2006.01); C07D 241/04 (2006.01); C07D 241/08 (2006.01); C07D 265/30 (2006.01); C07D 401/04 (2006.01); C07D 403/06 (2006.01); C07D 403/14 (2006.01); C07D 405/04 (2006.01); C07D 405/12 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07D 205/04 (2013.01); C07D 207/08 (2013.01); C07D 207/16 (2013.01); C07D 211/22 (2013.01); C07D 211/46 (2013.01); C07D 211/48 (2013.01); C07D 241/04 (2013.01); C07D 241/08 (2013.01); C07D 265/30 (2013.01); C07D 401/04 (2013.01); C07D 403/06 (2013.01); C07D 403/14 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 413/14 (2013.01); C07D 491/107 (2013.01);
Abstract

The present disclosure relates to novel compounds, and pharmaceutical compositions thereof, useful for treating for treating neurodegenerative diseases, including Alzheimer's disease and cognitive decline. Methods for inhibiting synapse number decline or membrane trafficking abnormalities associated with exposure of a neuronal cell to Abeta species are also disclosed. Representative members of these compounds include:

Find Patent Forward Citations

Rishton, Gilbert. (2022). Compositions for treating neurodegenerative diseases (U.S. Patent No. 11214540). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11214540

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…